3-(2,2,2-trimethylhydrazine)propionate and Cognition Disorders

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beitnere, U; Jansone, B; Kadish, I; Klusa, V; Kumar, A; van Groen, T	1

Other Studies

1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Cognition Disorders

Article	Year
Mildronate improves cognition and reduces amyloid-β pathology in transgenic Alzheimer's disease mice. Journal of neuroscience research, 2014, Volume: 92, Issue:3 Topics: Acetylcholinesterase; Adjuvants, Immunologic; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Glial Fibrillary Acidic Protein; Glutamate Decarboxylase; Humans; Locomotion; Methylhydrazines; Mice; Mice, Transgenic; Social Behavior	2014

Article

Year

Mildronate improves cognition and reduces amyloid-β pathology in transgenic Alzheimer's disease mice.

Journal of neuroscience research, 2014, Volume: 92, Issue:3

Topics: Acetylcholinesterase; Adjuvants, Immunologic; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Glial Fibrillary Acidic Protein; Glutamate Decarboxylase; Humans; Locomotion; Methylhydrazines; Mice; Mice, Transgenic; Social Behavior

2014